Skip to main content Skip to section navigation Skip to footer
Investor Relations
Back to heartbeam.com

HeartBeam, Inc.

Investor Relations
  • Investors
  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
    • Media
    • Media Archive
  • Company Info
    • Overview
    • Leadership
      • Management Team
      • Scientific Advisory Board
    • Presentations
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents

Media Archive

News & Events

News & Events

  • Overview
  • Press Releases
  • IR Calendar
  • Email Alerts
  • Media
  • Media Archive
April 28, 2023

HeartBeam Featured in Forbes Council Article: What Cardiologists Should Know About The Latest Technology In Home Heart Attack Detection

March 20, 2023

HeartBeam Featured in BioMedWire Article

March 6, 2023

HeartBeam Featured in TalkMarkets Article

March 3, 2023

HeartBeam Featured on Innovators with Jane King

February 17, 2023

HeartBeam Featured in Authority Magazine

February 14, 2023

HeartBeam Featured in eHealth Radio Interview

February 2, 2023

HeartBeam Featured in Quantum Research Group Report

January 11, 2023

HeartBeam Featured in TradersNewsSource.com Interview

December 15, 2022

HeartBeam Featured in Spotlight Growth Article: HeartBeam (NASDAQ: BEAT) Stands to Disrupt to Multi-Billion-Dollar Patch Market with its Patent-Protected 12-Lead ECG Patch Product

December 8, 2022

HeartBeam Featured in Spotlight Growth Article: HeartBeam (NASDAQ: BEAT): Innovative Technologies Disrupting the Old Standard of Care for Heart Patients and Upgrading ECG for the 21st Century

rss_feed RSS
  • 1
  • 2
  • arrow_forward
  • Email Alerts
  • Contacts
  • RSS News Feed

The HeartBeam System is a portable non-invasive recorder intended to record, store, and transfer a patient’s 3-Lead (in three-directions) electrocardiogram (ECG) acquired from 5 electrodes. The device is intended to be used by adult patients in either a clinical setting or at home. The device does not conduct cardiac analysis and can be used with an ECG Viewer software system for manual interpretation of non-life-threatening arrhythmias by a physician or healthcare professional.

The HeartBeam 12-Lead ECG Synthesis Software synthesizes a 12-Lead ECG from the HeartBeam System 3-Leads (in three-directions) recording device, producing a visual 12-Lead ECG representation that is similar, but not identical, to the same leads of a standard diagnostic 12-Lead ECG. The synthesized 12-Lead ECG output is solely intended for manual assessment of normal sinus rhythm and the following non-life-threatening arrhythmias: sinus arrhythmia, sinus tachycardia, sinus bradycardia, atrial premature complexes, atrial fibrillation, and ventricular premature complex. The synthesized 12-Lead ECG output is not intended for the assessment of any other arrhythmia or conditions (including but not limited to: other atrial arrhythmias, ventricular arrhythmias, hypertrophy, conduction disorders, myocardial infarction or ischemia, pacemaker functions, localization of arrhythmia foci, ECG wave abnormalities, and/or any other disorder). The software does not conduct cardiac analysis and is not intended to replace a standard 12-Lead ECG. The 12-Lead ECG Synthesis Software is intended for adult use only. For full safety information, see the full Instructions for Use or Clinician Portal Manual.

© 2025 HeartBeam, Inc. All Rights Reserved.
Privacy Policy Disclaimer Sitemap